Cargando…
Gastrointestinal Permeation Enhancers for the Development of Oral Peptide Pharmaceuticals
Recently, two oral-administered peptide pharmaceuticals, semaglutide and octreotide, have been developed and are considered as a breakthrough in peptide and protein drug delivery system development. In 2019, the Food and Drug Administration (FDA) approved an oral dosage form of semaglutide developed...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781085/ https://www.ncbi.nlm.nih.gov/pubmed/36559036 http://dx.doi.org/10.3390/ph15121585 |